A Prospective, Multicenter Phase II Study of the Efficacy and Feasibility of 15-Minute Panitumumab Infusion Plus Irinotecan for Oxaliplatin- and Irinotecan-refractory, KRAS Wild-type Metastatic Colorectal Cancer (short Infusion of Panitumumab Trial).

Kohei Akiyoshi,Tetsuya Hamaguchi,Kenichi Yoshimura,Naoki Takahashi,Yoshitaka Honma,Satoru Iwasa,Atsuo Takashima,Ken Kato,Yasuhide Yamada,Hisashi Onodera,Shigeyuki Takeshita,Hisateru Yasui,Gen Sakai,Sotaro Akatsuka, Kohei Ogawa,Yosuke Horita,Yushi Nagai,Yasuhiro Shimada

Clinical colorectal cancer（2018）

引用 4|浏览17
暂无评分
关键词
Anti-EGFR therapy,Convenience of outpatient,Fully humanized monoclonal antibody,Infusion-related reaction,mCRC
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要